These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 11762040)

  • 1. [Gene therapy for hepatocellular carcinoma].
    Ohashi M; Kanai F; Shiratori Y; Omata M
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():699-704. PubMed ID: 11762040
    [No Abstract]   [Full Text] [Related]  

  • 2. [Gene therapy of primary cancers of the liver: hopes and realities].
    Ferry N
    Bull Cancer; 1997 Apr; 84(4):431-4. PubMed ID: 9238170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene therapy for alpha-fetoprotein-producing human hepatoma cells by adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene.
    Kanai F; Shiratori Y; Yoshida Y; Wakimoto H; Hamada H; Kanegae Y; Saito I; Nakabayashi H; Tamaoki T; Tanaka T; Lan KH; Kato N; Shiina S; Omata M
    Hepatology; 1996 Jun; 23(6):1359-68. PubMed ID: 8675152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [In vitro model for the suicide gene therapy of AFP-producing gastric cancer using HSVtk gene under control of AFP promoter].
    Nakaya H
    Hokkaido Igaku Zasshi; 2003 May; 78(3):203-9. PubMed ID: 12795172
    [No Abstract]   [Full Text] [Related]  

  • 5. Restriction of tumoricidal gene therapy to selected hepatocellular carcinoma cells.
    Gagandeep S; Gupta S
    Hepatology; 1996 Nov; 24(5):1317-9. PubMed ID: 8903416
    [No Abstract]   [Full Text] [Related]  

  • 6. Gene therapy targeting for hepatocellular carcinoma: selective and enhanced suicide gene expression regulated by a hypoxia-inducible enhancer linked to a human alpha-fetoprotein promoter.
    Ido A; Uto H; Moriuchi A; Nagata K; Onaga Y; Onaga M; Hori T; Hirono S; Hayashi K; Tamaoki T; Tsubouchi H
    Cancer Res; 2001 Apr; 61(7):3016-21. PubMed ID: 11306481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrovirus-mediated gene therapy for hepatocellular carcinoma with reversely oriented therapeutic gene expression regulated by alpha-fetoprotein enhancer/promoter.
    Ishikawa H; Nakata K; Mawatari F; Ueki T; Tsuruta S; Ido A; Nakao K; Kato Y; Ishii N; Eguchi K
    Biochem Biophys Res Commun; 2001 Oct; 287(4):1034-40. PubMed ID: 11573968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenovirus-mediated gene therapy of hepatocellular carcinoma using cancer-specific gene expression.
    Kaneko S; Hallenbeck P; Kotani T; Nakabayashi H; McGarrity G; Tamaoki T; Anderson WF; Chiang YL
    Cancer Res; 1995 Nov; 55(22):5283-7. PubMed ID: 7585589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utilization of variant-type of human alpha-fetoprotein promoter in gene therapy targeting for hepatocellular carcinoma.
    Ishikawa H; Nakata K; Mawatari F; Ueki T; Tsuruta S; Ido A; Nakao K; Kato Y; Ishii N; Eguchi K
    Gene Ther; 1999 Apr; 6(4):465-70. PubMed ID: 10476206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrovirus-mediated gene therapy for hepatocellular carcinoma: selective and enhanced suicide gene expression regulated by human alpha-fetoprotein enhancer directly linked to its promoter.
    Mawatari F; Tsuruta S; Ido A; Ueki T; Nakao K; Kato Y; Tamaoki T; Ishii N; Nakata K
    Cancer Gene Ther; 1998; 5(5):301-6. PubMed ID: 9824049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eradication of hepatocellular carcinoma xenografts by radiolabelled, lipiodol-inducible gene therapy.
    Kawashita Y; Ohtsuru A; Miki F; Kuroda H; Morishita M; Kaneda Y; Hatsushiba K; Kanematsu T; Yamashita S
    Gene Ther; 2005 Nov; 12(22):1633-9. PubMed ID: 16079887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Gene therapy for hepatocellular carcinoma. From the idea to clinical trials].
    Gerolami R; Uch R; Cardoso J; Bagnis C; Mannoni P; Bréchot C
    Gastroenterol Clin Biol; 2001 Mar; 25(3):273-86. PubMed ID: 11395675
    [No Abstract]   [Full Text] [Related]  

  • 13. Gene therapy for hepatoma cells using a retrovirus vector carrying herpes simplex virus thymidine kinase gene under the control of human alpha-fetoprotein gene promoter.
    Ido A; Nakata K; Kato Y; Nakao K; Murata K; Fujita M; Ishii N; Tamaoki T; Shiku H; Nagataki S
    Cancer Res; 1995 Jul; 55(14):3105-9. PubMed ID: 7541712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Gene therapy for hepatocellular carcinoma].
    Hirano T; Fujimoto J
    Nihon Rinsho; 2005 Dec; 63 Suppl 12():512-6. PubMed ID: 16416844
    [No Abstract]   [Full Text] [Related]  

  • 15. Transduction efficacy, antitumoral effect, and toxicity of adenovirus-mediated herpes simplex virus thymidine kinase/ ganciclovir therapy of hepatocellular carcinoma: the woodchuck animal model.
    Bilbao R; Gérolami R; Bralet MP; Qian C; Tran PL; Tennant B; Prieto J; Bréchot C
    Cancer Gene Ther; 2000 May; 7(5):657-62. PubMed ID: 10830712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased efficacy and safety in the treatment of experimental liver cancer with a novel adenovirus-alphavirus hybrid vector.
    Guan M; Rodriguez-Madoz JR; Alzuguren P; Gomar C; Kramer MG; Kochanek S; Prieto J; Smerdou C; Qian C
    Cancer Res; 2006 Feb; 66(3):1620-9. PubMed ID: 16452221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 gene therapy in vivo of herpatocellular and liver metastatic colorectal cancer.
    Bookstein R; Demers W; Gregory R; Maneval D; Park J; Wills K
    Semin Oncol; 1996 Feb; 23(1):66-77. PubMed ID: 8607033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Construction and study of replication-defective adenovirus targeting hepatocarcinoma].
    Xu DY; Du ZY; Wang Y; Chen HH; Xu YJ; Lu YL
    Ai Zheng; 2006 Jul; 25(7):798-804. PubMed ID: 16831267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene therapy for hepatocellular carcinoma.
    Aggarwal A; Aggarwal R
    Natl Med J India; 1992; 5(4):171-2. PubMed ID: 1338969
    [No Abstract]   [Full Text] [Related]  

  • 20. HVJ-liposome-mediated transfection of HSVtk gene driven by AFP promoter inhibits hepatic tumor growth of hepatocellular carcinoma in SCID mice.
    Hirano T; Kaneko S; Kaneda Y; Saito I; Tamaoki T; Furuyama J; Tamaoki T; Kobayashi K; Ueki T; Fujimoto J
    Gene Ther; 2001 Jan; 8(1):80-3. PubMed ID: 11402306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.